Stock 9939 KINTOR PHARMACEUTICAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Kintor Pharmaceutical Limited

Equities

9939

KYG5273B1077

Delayed Hong Kong S.E.
Other stock markets
 10:21:50 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.94 HKD -2.08% Intraday chart for Kintor Pharmaceutical Limited -2.08% -42.33%
Apr. 22 Kintor Pharmaceutical Limited Announces Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China Reaches Primary Endpoint CI
Apr. 22 Kintor Pharmaceutical Concludes Phase II Clinical Trial for Androgenic Alopecia Treatment MT

Evolution of the average Target Price on Kintor Pharmaceutical Limited

Price target over the last 5 years

History of analyst recommendation changes

66c3c0e7d.aLrDFbZjOFurVH_KUlDMxMlVUeielR1IdN_xwIN1Ans.DPuNbO4laSveMgeCCiOu9_wyO4DcrW4JGJ6a-fs9ND0Y3fpa8g9AFsEzKg~c4da0ce3626de1246a111b6ea9910400

Analyst Recommendations on Kintor Pharmaceutical Limited

Kintor Proxalutamide's Covid-19 Clinical Trial Shows Significant Reduction in Hospitalization and Ventilation Rates CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.888 CNY
Average target price
13.21 CNY
Spread / Average Target
+1,387.63%
High Price Target
13.21 CNY
Spread / Highest target
+1,387.63%
Low Price Target
13.21 CNY
Spread / Lowest Target
+1,387.63%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 9939 Stock
  4. Consensus Kintor Pharmaceutical Limited